Sheng Han

9PUBLICATIONS
12CO-AUTHORS
Vision scienceMedical bacteriologyGene and molecular therapyPredictive and prognostic markersEconomic models and forecasting
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 18, 2026
Cost-effectiveness analysis of the use of faricimab in diabetic macular edema in China.

Fenghao Shi, Shuhua Tan, Yamin Shu

|Mar 13, 2026
Lefamulin versus omadacycline for community acquired bacterial pneumonia: a systematic review and anchored indirect treatment comparison using moxifloxacin as the common comparator.

Meiyu Wu, Sheng Han, Hongchao Li

|May 19, 2025
A value framework for lymphoma therapies based on MACBETH method.

Yumei He, Wei Li, Xiaochen Zhu

|Oct 01, 2024
Cost-effectiveness analysis of selpercatinib versus chemotherapy and pembrolizumab in the first-line treatment of rearranged during transfection fusion-positive non-small cell lung cancer in the United States.

Hongbin Yi, Yingdan Cao, Fenghao Shi

|Jul 11, 2024
Cost-effectiveness analysis of amivantamab plus chemotherapy for non-small cell lung cancer patients with epidermal growth factor receptor exon 20 insertions in the United States.

Yingdan Cao, Hongbin Yi, Fenghao Shi

|May 30, 2024
Influencing Factors of Generic Prescribing Behavior of Physicians: A Structural Equation Model Based on the Theory of Planned Behavior.

Zhiyuan Wang, Ruilin Wang, Xiaoyu Li

Pageof 2

Frequent Collaborators

3 joint publications

Fenghao Shi

2 joint publications

Yingdan Cao

2 joint publications

Hongbin Yi

2 joint publications

Xiaoxia Wei